United States · FDA National Drug Code directory
Cardiolite
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 87333-001_258f6ed0-be7d-4c94-b737-fd822eb58c6c
- Product NDC
- 87333-001
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE
- Labeler
- SHINE SPECT USA, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20260910
- Source listing expiry
- 20271231
Source-listed ingredients
- TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE — 1 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 20 VIAL in 1 BOX (87333-001-20) / 5 mL in 1 VIAL · 87333-001-20
- 5 VIAL in 1 BOX (87333-001-55) / 5 mL in 1 VIAL · 87333-001-55
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →